{"product_id":"ipamorelin-10mg","title":"Ipamorelin 10mg","description":"\u003cdiv class=\"pp-desc\"\u003e\n\u003ch2 style=\"font-size:18px;font-weight:600;margin:0 0 12px\"\u003eCompound Overview\u003c\/h2\u003e\n\u003cdiv style=\"margin:0 0 18px;padding:14px 16px;background:#eef0ff;border:1px solid #d9dbff;border-left:4px solid #5b5ef6;border-radius:0 10px 10px 0\"\u003e\u003cp style=\"margin:0;font-size:14px;color:#1a1a1a;line-height:1.6\"\u003e\u003cstrong style=\"color:#4d3fd6\"\u003e✓ Third-party COA published on arrival.\u003c\/strong\u003e Every batch of Ipamorelin is independently verified by HPLC-UV for purity and mass spectrometry for identity before release, with the batch-specific certificate posted to our \u003ca href=\"\/pages\/lab-results\" style=\"color:#5b5ef6;font-weight:600\"\u003eLab Results page\u003c\/a\u003e. The current lot is \u003cstrong\u003eip10-0626-01\u003c\/strong\u003e, assayed by Janoshik Analytical (report #169441, June 2026) at \u003cstrong\u003e99.673% purity\u003c\/strong\u003e. Testides (Toronto) confirmation pending.\u003c\/p\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin (NNC 26-0161) is a selective growth hormone secretagogue — a pentapeptide agonist of the ghrelin \/ growth hormone secretagogue receptor (GHS-R1a).\u003c\/strong\u003e It is frequently described in the literature as the first GH secretagogue to release growth hormone with high selectivity, meaning that in the foundational research it stimulated GH without meaningfully raising ACTH, cortisol, or prolactin — a profile that distinguishes it from earlier secretagogues such as GHRP-2 and GHRP-6.\u003c\/p\u003e\n\u003cp\u003eEach vial contains 10mg of lyophilized Ipamorelin. CAS Number: 170851-70-4.\u003c\/p\u003e\n\u003cp\u003eFor a full scientific overview of Ipamorelin, see our \u003ca href=\"\/blogs\/research\/ipamorelin-canada\" style=\"color:#5b5ef6\"\u003eIpamorelin Research Guide\u003c\/a\u003e or browse the \u003ca href=\"\/blogs\/research\" style=\"color:#5b5ef6\"\u003eResearch Hub\u003c\/a\u003e. To compare it with the paired compound, see the \u003ca href=\"\/blogs\/research\/cjc-1295-ipamorelin-canada\" style=\"color:#5b5ef6\"\u003eCJC-1295 + Ipamorelin guide\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch2 style=\"font-size:16px;font-weight:600;margin:26px 0 10px\"\u003eSpecifications\u003c\/h2\u003e\n\u003ctable style=\"width:100%;border-collapse:collapse;font-size:14px\"\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600;width:42%\"\u003eCompound\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eIpamorelin (NNC 26-0161)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eCompound class\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eSelective growth hormone secretagogue — ghrelin \/ GHS-R1a receptor agonist\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eCAS number\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003e170851-70-4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eMolecular formula\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eC\u003csub\u003e38\u003c\/sub\u003eH\u003csub\u003e49\u003c\/sub\u003eN\u003csub\u003e9\u003c\/sub\u003eO\u003csub\u003e5\u003c\/sub\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eMolecular weight\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003e711.85 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eAmino acid sequence\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eAib-His-D-2-Nal-D-Phe-Lys-NH\u003csub\u003e2\u003c\/sub\u003e (pentapeptide)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eVial contents\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003e10 mg lyophilized powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eCurrent lot\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eip10-0626-01 (Janoshik report #169441, June 2026)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eVerified purity\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003e99.673% (HPLC-UV)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eIdentity confirmation\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eMass spectrometry confirmed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eStorage\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eLyophilized: -20°C long-term, 2-8°C short-term\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eResearch applications\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eGHS-R1a receptor pharmacology, pulsatile GH-release models, secretagogue selectivity comparison (ACTH \/ cortisol \/ prolactin), gastric-motility research models\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eRelated compounds\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003e\n\u003ca href=\"\/products\/cjc-1295-ipamorelin\" style=\"color:#5b5ef6\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e (a separate, paired secretagogue + GHRH-analog product)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eShips from\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eBritish Columbia, Canada\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb;font-weight:600\"\u003eIntended use\u003c\/td\u003e\n\u003ctd style=\"padding:7px 10px;border-bottom:1px solid #e5e7eb\"\u003eIn-vitro laboratory research only\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003cdetails style=\"border-top:1px solid #e5e7eb;margin-top:24px\"\u003e\u003csummary style=\"font-weight:600;padding:14px 0;cursor:pointer;list-style:none;display:flex;justify-content:space-between;align-items:center\"\u003eResearch Context \u0026amp; Mechanism\u003cspan style=\"color:#5b5ef6;font-size:18px\"\u003e+\u003c\/span\u003e\u003c\/summary\u003e\u003cdiv style=\"padding:0 0 16px;font-size:14px;line-height:1.7;color:#444\"\u003e\n\u003cp\u003eIpamorelin binds the growth hormone secretagogue receptor (GHS-R1a), the same receptor targeted by the endogenous hormone ghrelin. Activation at the pituitary drives release of stored growth hormone in a pulsatile fashion. Because it acts as a secretagogue — prompting release of the body's own GH rather than supplying GH directly — it is studied as a tool compound for probing the GH axis.\u003c\/p\u003e\n\u003cp\u003eIts defining characteristic in the literature is \u003cstrong\u003eselectivity\u003c\/strong\u003e. In the foundational characterization by Raun and colleagues (1998), Ipamorelin released growth hormone with a potency comparable to GHRP-6, but — unlike GHRP-6 and GHRP-2 — did so without significant elevation of ACTH or cortisol, and without meaningfully affecting prolactin, FSH, LH, or TSH. This \"clean\" GH-selective profile is the reason it is often referenced as the first selective GH secretagogue.\u003c\/p\u003e\n\u003cp\u003eBeyond the GH axis, Ipamorelin has been examined in gastrointestinal-motility research as a ghrelin-mimetic, including rodent models of postoperative ileus (gastric dysmotility).\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"\/blogs\/research\/ipamorelin-canada\" style=\"color:#5b5ef6\"\u003eRead the full Ipamorelin Research Guide →\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/details\u003e\u003cdetails style=\"border-top:1px solid #e5e7eb\"\u003e\u003csummary style=\"font-weight:600;padding:14px 0;cursor:pointer;list-style:none;display:flex;justify-content:space-between;align-items:center\"\u003eSelectivity vs Other Secretagogues\u003cspan style=\"color:#5b5ef6;font-size:18px\"\u003e+\u003c\/span\u003e\u003c\/summary\u003e\u003cdiv style=\"padding:0 0 16px;font-size:14px;line-height:1.7;color:#444\"\u003e\n\u003cp\u003eA common reason Ipamorelin appears in comparative research is its narrow hormonal footprint relative to earlier growth hormone-releasing peptides:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHRP-6:\u003c\/strong\u003e reported in the source literature to release GH, with concurrent orexigenic activity and elevation of cortisol\/ACTH.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHRP-2 (pralmorelin):\u003c\/strong\u003e potent GH release, but with more pronounced ACTH, cortisol, and prolactin effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIpamorelin:\u003c\/strong\u003e GH release comparable to GHRP-6 in the original work, with ACTH and cortisol reported at or near baseline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt is frequently studied alongside the GHRH analog \u003ca href=\"\/products\/cjc-1295-ipamorelin\" style=\"color:#5b5ef6\"\u003eCJC-1295\u003c\/a\u003e, because a GHRH analog plus a GHS-R agonist act on two complementary pathways of the GH axis.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/details\u003e\u003cdetails style=\"border-top:1px solid #e5e7eb\"\u003e\u003csummary style=\"font-weight:600;padding:14px 0;cursor:pointer;list-style:none;display:flex;justify-content:space-between;align-items:center\"\u003eDevelopment Status \u0026amp; Honest Limits\u003cspan style=\"color:#5b5ef6;font-size:18px\"\u003e+\u003c\/span\u003e\u003c\/summary\u003e\u003cdiv style=\"padding:0 0 16px;font-size:14px;line-height:1.7;color:#444\"\u003e\n\u003cp\u003eIpamorelin was originally developed by Novo Nordisk (as NNC 26-0161) and later investigated by Helsinn Therapeutics in Phase II trials for postoperative ileus. That clinical program was \u003cstrong\u003ediscontinued for lack of efficacy on its primary endpoint\u003c\/strong\u003e, and Ipamorelin has never been approved as a therapeutic drug. Most of the human GH-release data comes from small early-phase pharmacology studies rather than large controlled trials.\u003c\/p\u003e\n\u003cp\u003eWe flag this deliberately: the selectivity findings are well characterized in preclinical and early clinical work, but Ipamorelin remains an investigational research compound, not an approved medicine.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/details\u003e\u003cdetails style=\"border-top:1px solid #e5e7eb\"\u003e\u003csummary style=\"font-weight:600;padding:14px 0;cursor:pointer;list-style:none;display:flex;justify-content:space-between;align-items:center\"\u003ePurity \u0026amp; Third-Party Testing\u003cspan style=\"color:#5b5ef6;font-size:18px\"\u003e+\u003c\/span\u003e\u003c\/summary\u003e\u003cdiv style=\"padding:0 0 16px;font-size:14px;line-height:1.7;color:#444\"\u003e\n\u003cp\u003eEvery batch of Ipamorelin is independently tested using HPLC-UV for purity verification and mass spectrometry for molecular identity confirmation. The batch-specific Certificate of Analysis (COA) is published on our \u003ca href=\"\/pages\/lab-results\" style=\"color:#5b5ef6\"\u003eLab Results page\u003c\/a\u003e, and the current lot ip10-0626-01 was assayed by Janoshik Analytical (report #169441, June 2026) at 99.673% purity, as listed in the specifications table above. Testides (Toronto) confirmation pending.\u003c\/p\u003e\n\u003cp\u003eNew to reading a COA? See our guide on \u003ca href=\"\/blogs\/news\/how-to-read-peptide-coa\" style=\"color:#5b5ef6\"\u003ehow to read a peptide certificate of analysis\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/details\u003e\u003cdetails style=\"border-top:1px solid #e5e7eb\"\u003e\u003csummary style=\"font-weight:600;padding:14px 0;cursor:pointer;list-style:none;display:flex;justify-content:space-between;align-items:center\"\u003eStorage \u0026amp; Handling\u003cspan style=\"color:#5b5ef6;font-size:18px\"\u003e+\u003c\/span\u003e\u003c\/summary\u003e\u003cdiv style=\"padding:0 0 16px;font-size:14px;line-height:1.7;color:#444\"\u003e\n\u003cp\u003eIpamorelin is supplied as a lyophilized (freeze-dried) powder for maximum stability.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLyophilized (unopened):\u003c\/strong\u003e Store at -20°C long-term or 2-8°C short-term\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLight:\u003c\/strong\u003e Protect from direct light at all times\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTemperature cycling:\u003c\/strong\u003e Keep the sealed vial at a steady temperature and limit warm\/cold swings. A manual-defrost freezer, or the back of a frost-free unit, holds a more stable temperature than a door shelf.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCondensation:\u003c\/strong\u003e Let a cold, still-sealed vial come up to room temperature before the seal is broken, so atmospheric moisture does not condense onto the powder.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003c\/details\u003e\u003cdetails style=\"border-top:1px solid #e5e7eb\"\u003e\u003csummary style=\"font-weight:600;padding:14px 0;cursor:pointer;list-style:none;display:flex;justify-content:space-between;align-items:center\"\u003eHow fast does Ipamorelin ship in Canada, and is shipping free?\u003cspan style=\"color:#5b5ef6;font-size:18px\"\u003e+\u003c\/span\u003e\u003c\/summary\u003e\u003cdiv style=\"padding:0 0 16px;font-size:14px;line-height:1.7;color:#444\"\u003e\n\u003cp\u003e\u003cstrong\u003eShipping is free on every order, Canada-wide, with no minimum order value\u003c\/strong\u003e, and every parcel is tracked. All orders ship from British Columbia, Canada.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eProcessing:\u003c\/strong\u003e Dispatched within 48 hours (Mon-Fri)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDelivery:\u003c\/strong\u003e Typically 2-8 business days anywhere in Canada\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTracking:\u003c\/strong\u003e A tracking number is emailed as soon as your order ships\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAll research compounds are packaged in temperature-stable, tamper-evident materials. Vials are individually wrapped in discreet, unbranded packaging.\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"\/pages\/shipping-policy\" style=\"color:#5b5ef6\"\u003eView full shipping policy →\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/details\u003e\u003cdetails style=\"border-top:1px solid #e5e7eb;border-bottom:1px solid #e5e7eb\"\u003e\u003csummary style=\"font-weight:600;padding:14px 0;cursor:pointer;list-style:none;display:flex;justify-content:space-between;align-items:center\"\u003eReturns \u0026amp; Refunds\u003cspan style=\"color:#5b5ef6;font-size:18px\"\u003e+\u003c\/span\u003e\u003c\/summary\u003e\u003cdiv style=\"padding:0 0 16px;font-size:14px;line-height:1.7;color:#444\"\u003e\n\u003cp\u003eIf your order arrives damaged or does not arrive within the expected timeframe, contact us at \u003ca href=\"mailto:info@thepeptide.ca\" style=\"color:#5b5ef6\"\u003einfo@thepeptide.ca\u003c\/a\u003e within 48 hours of the expected delivery date. Include your order number and photos of any damage.\u003c\/p\u003e\n\u003cp\u003eDue to the nature of research compounds, we cannot accept returns on opened or prepared products. Sealed, unopened vials may be eligible for exchange within 14 days of delivery.\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"\/policies\/refund-policy\" style=\"color:#5b5ef6\"\u003eView full refund policy →\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/details\u003e\u003ch2 style=\"font-size:16px;font-weight:600;margin:26px 0 10px\"\u003eKey research references\u003c\/h2\u003e\n\u003cul style=\"font-size:13px;line-height:1.7;color:#444\"\u003e\n\u003cli\u003eRaun K, et al. \u003cem\u003eIpamorelin, the first selective growth hormone secretagogue.\u003c\/em\u003e European Journal of Endocrinology, 1998;139(5):552-561.\u003c\/li\u003e\n\u003cli\u003eGobburu JVS, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. \u003cem\u003ePharmaceutical Research\u003c\/em\u003e, 1999.\u003c\/li\u003e\n\u003cli\u003eVenkova K, et al. \u003cem\u003eEfficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus.\u003c\/em\u003e 2016 (PubMed 27186127).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv style=\"margin-top:24px;padding:14px 16px;background:#f0faf5;border-left:4px solid #0f6e56;border-radius:0 8px 8px 0\"\u003e\u003cp style=\"margin:0;font-size:14px;color:#1a1a1a\"\u003e\u003cstrong\u003eFor laboratory and research use only.\u003c\/strong\u003e Not for human consumption, veterinary use, or therapeutic application. Not approved by Health Canada. All ThePeptide.ca materials are intended strictly for qualified research purposes. We do not provide preparation, dilution or administration guidance for any compound we sell.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"ThePeptide","offers":[{"title":"Default Title","offer_id":46118281478214,"sku":"IPAM-10MG","price":74.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0734\/3020\/4486\/files\/09-12_Ipamorelin.png?v=1789272437","url":"https:\/\/thepeptide.ca\/products\/ipamorelin-10mg","provider":"ThePeptide","version":"1.0","type":"link"}